• Profile
Close

Endometrial safety of low-dose vaginal estrogens in menopausal women: A systematic evidence review

Menopause Jul 16, 2019

Constantine G, et al. - Researchers systematically reviewed 36 articles and 2 abstracts, describing 20 randomized controlled studies, 8 interventional studies, and 10 observational studies, to assess the incidence of endometrial hyperplasia or cancer with unopposed vaginal estrogens. Collectively, the studies indicated no heightened risk of endometrial hyperplasia or cancer with low-dose vaginal estrogens. For treating vulvar and vaginal atrophy in menopausal women without a concomitant progestogen, low-dose vaginal estrogens are identified as valuable.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay